![{[Name]}](https://resource.bocsci.com/structure/98924-81-3.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/1817735-35-5.gif?v=2025011501)
![{[Name]}](/probes/images/structure-default.jpg?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/653600-56-7.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/1835759-68-6.gif?v=2025011501)
Inquiry Basket
Aminooxy-PEG2-azide | CAS 1043426-13-6
| Catalog Number | R14-0256 |
| Category | Azides |
| Molecular Formula | C6H14N4O3 |
| Molecular Weight | 190.20 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Aminooxy-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Aminooxy-PEG2-azide is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Chemical Information
Product Specification
Computed Properties
Patents
| Synonyms | O-(2-(2-(2-azidoethoxy)ethoxy)ethyl)hydroxylamine |
| Purity | >98% |
| Shelf Life | -20°C 3 years powder; -80°C 2 years in solvent |
| IUPAC Name | O-[2-[2-(2-azidoethoxy)ethoxy]ethyl]hydroxylamine |
| Canonical SMILES | C(COCCOCCON)N=[N+]=[N-] |
| InChI | InChI=1S/C6H14N4O3/c7-10-9-1-2-11-3-4-12-5-6-13-8/h1-6,8H2 |
| InChIKey | GCURLNTZWQFVMK-UHFFFAOYSA-N |
| Solubility | 10 mm in DMSO |
| Storage | -20°C |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 190.10659032 g/mol |
| Monoisotopic Mass | 190.10659032 g/mol |
| Topological Polar Surface Area | 68.1Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 149 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
| Publication Number | Title | Priority Date |
|---|---|---|
| US-10029014-B2 | Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery | 2013-09-10 |
| US-2016220688-A1 | Synthesis of novel asymmetric bow-tie pamam dendrimer-based conjugates for tumor-targeting drug delivery | 2013-09-10 |
Recommended Services
Recommended Articles
- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry
